According to XYZResearch study, over the next five years the Cancer Antibody Drug Conjugatesmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Cancer Antibody Drug Conjugatesbusiness.
Cancer Antibody Drug Conjugates market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO. The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch's analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Cancer Antibody Drug Conjugates for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global Cancer Antibody Drug Conjugates market competition by top manufacturers/players, with Cancer Antibody Drug Conjugates sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Novartis
Merck
Roche
AbbVie
UCB
Bristol-Myers Squibb
Stem CentRx
Biogen Idec
Nordic Nanovector
Millennium
Biotest AG
PDL BioPharma
Progenics Pharmaceuticals
Seattle Genetics
Viventia Biotechnologies
AbGenomics Corporation
Helix BioPharma
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
First & Second Generation ADCs
Third Generation ADCs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Cancer Antibody Drug Conjugates for each application, including
Hospitals
Clinics
Other
Feel free to let me know if you have any special requirements.
Table of Contents
1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Cancer Antibody Drug Conjugates Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 First & Second Generation ADCs
2.1.2 Third Generation ADCs
2.2 Overall Market Performance(Value)
2.2.1 First & Second Generation ADCs
2.2.2 Third Generation ADCs
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Other
4 Manufacturers Profiles/Analysis
4.1 Novartis
4.1.1 Novartis Profiles
4.1.2 Novartis Product Information
4.1.3 Novartis Cancer Antibody Drug Conjugates Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 Novartis SWOT Analysis
4.2 Merck
4.2.1 Merck Profiles
4.2.2 Merck Product Information
4.2.3 Merck Cancer Antibody Drug ConjugatesSales, Sales Value (Million USD), Price and Gross Profit
4.2.4 Merck SWOT Analysis
4.3 Roche
4.3.1 Roche Profiles
4.3.2 Roche Product Information
4.3.3 Roche Cancer Antibody Drug ConjugatesSales, Sales Value (Million USD), Price and Gross Profit
4.3.4 Roche SWOT Analysis
4.4 AbbVie
4.4.1 AbbVie Profiles
4.4.2 AbbVie Product Information
4.4.3 AbbVie Cancer Antibody Drug ConjugatesSales, Sales Value (Million USD), Price and Gross Profit
4.4.4 AbbVie SWOT Analysis
4.5 UCB
4.5.1 UCB Profiles
4.5.2 UCB Product Information
4.5.3 UCB Cancer Antibody Drug ConjugatesSales, Sales Value (Million USD), Price and Gross Profit
4.5.4 UCB SWOT Analysis
4.6 Bristol-Myers Squibb
4.6.1 Bristol-Myers Squibb Profiles
4.6.2 Bristol-Myers Squibb Product Information
4.6.3 Bristol-Myers Squibb Cancer Antibody Drug ConjugatesSales, Sales Value (Million USD), Price and Gross Profit
4.6.4 Bristol-Myers Squibb SWOT Analysis
4.7 Stem CentRx
4.7.1 Stem CentRx Profiles
4.7.2 Stem CentRx Product Information
4.7.3 Stem CentRx Cancer Antibody Drug ConjugatesSales, Sales Value (Million USD), Price and Gross Profit
4.7.4 Stem CentRx SWOT Analysis
4.8 Biogen Idec
4.8.1 Biogen Idec Profiles
4.8.2 Biogen Idec Product Information
4.8.3 Biogen Idec Cancer Antibody Drug ConjugatesSales, Sales Value (Million USD), Price and Gross Profit
4.8.4 Biogen Idec SWOT Analysis
4.9 Nordic Nanovector
4.9.1 Nordic Nanovector Profiles
4.9.2 Nordic Nanovector Product Information
4.9.3 Nordic Nanovector Cancer Antibody Drug ConjugatesSales, Sales Value (Million USD), Price and Gross Profit
4.9.4 Nordic Nanovector SWOT Analysis
4.10 Millennium
4.10.1 Millennium Profiles
4.10.2 Millennium Product Information
4.10.3 Millennium Cancer Antibody Drug ConjugatesSales, Sales Value (Million USD), Price and Gross Profit
4.10.4 Millennium SWOT Analysis
4.11 Biotest AG
4.12 PDL BioPharma
4.13 Progenics Pharmaceuticals
4.14 Seattle Genetics
4.15 Viventia Biotechnologies
4.16 AbGenomics Corporation
4.17 Helix BioPharma
5 Market Performance for Manufacturers
5.1 Global Cancer Antibody Drug Conjugates Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global Cancer Antibody Drug Conjugates Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global Cancer Antibody Drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global Cancer Antibody Drug Conjugates Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Cancer Antibody Drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China Cancer Antibody Drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China Cancer Antibody Drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China Cancer Antibody Drug Conjugates Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Cancer Antibody Drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA Cancer Antibody Drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA Cancer Antibody Drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA Cancer Antibody Drug Conjugates Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Cancer Antibody Drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe Cancer Antibody Drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe Cancer Antibody Drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe Cancer Antibody Drug Conjugates Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Cancer Antibody Drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan Cancer Antibody Drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan Cancer Antibody Drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan Cancer Antibody Drug Conjugates Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Cancer Antibody Drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea Cancer Antibody Drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea Cancer Antibody Drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea Cancer Antibody Drug Conjugates Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Cancer Antibody Drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India Cancer Antibody Drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India Cancer Antibody Drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India Cancer Antibody Drug Conjugates Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Cancer Antibody Drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia Cancer Antibody Drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia Cancer Antibody Drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia Cancer Antibody Drug Conjugates Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Cancer Antibody Drug Conjugates Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America Cancer Antibody Drug Conjugates Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America Cancer Antibody Drug Conjugates Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America Cancer Antibody Drug Conjugates Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global Cancer Antibody Drug Conjugates Market Assessment by Regions (2014-2020)
7.1 Global Cancer Antibody Drug Conjugates Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global Cancer Antibody Drug Conjugates Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global Cancer Antibody Drug Conjugates Price (USD/Unit) by Regions 2014-2020
7.4 Global Cancer Antibody Drug Conjugates Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global Cancer Antibody Drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China Cancer Antibody Drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA Cancer Antibody Drug Conjugates Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe Cancer Antibody Drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan Cancer Antibody Drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea Cancer Antibody Drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India Cancer Antibody Drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Cancer Antibody Drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Cancer Antibody Drug Conjugates Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Hospitals Industry
11.2 Clinics Industry
11.3 Other Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global Cancer Antibody Drug Conjugates Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global Cancer Antibody Drug Conjugates Sales (K Units) and Growth Rate 2021-2026
12.1.3 China Cancer Antibody Drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA Cancer Antibody Drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe Cancer Antibody Drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan Cancer Antibody Drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea Cancer Antibody Drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India Cancer Antibody Drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia Cancer Antibody Drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America Cancer Antibody Drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 First & Second Generation ADCs
12.2.3 Third Generation ADCs
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Hospitals
12.3.3 Clinics
12.3.4 Other
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Cancer Antibody Drug Conjugates Price (USD/Unit) Trend 2021-2026
12.4.2 Global Cancer Antibody Drug Conjugates Gross Profit Trend 2021-2026
13 Conclusion
The Drug Temperature Monitoring System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
The Small Molecule Drug CDMO Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
Executive Summary
Azoth Analytics has released a research report titled "Global Immune Thrombocytopenia Drug Market (2024 Edition)" which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglob...
Executive Summary
Azoth Analytics has released a research report titled "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)" which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market segmentatio...
Executive Summary
Azoth Analytics has released a research report titled "Global Irritable Bowel Disease Market (2024 Edition)" which provides a complete analysis of the Global Irritable Bowel Disease industry in terms of market segmentation By Drug Class (Corticosteroids, JAK inhibitors...
The Intelligent Drug Delivery Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The Contract Drug Discovery Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Automatic Sales Enablement System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Computer-assisted Drug Design Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
Executive Summary
Azoth Analytics has released a research report titled "Global Therapeutic Antibody Market (2023 Edition)" which provides a complete analysis of the Global Therapeutic Antibody industry in terms of market segmentation By Product Type (Monoclonal Antibody, Bispecific Ant...